Menu Search
Equities

Shanghai Haixin Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
900917:SHH

Shanghai Haixin Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.273
  • Today's Change-0.001 / -0.36%
  • Shares traded887.21k
  • 1 Year change-2.50%
  • Beta1.1555
Data delayed at least 15 minutes, as of Mar 03 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Haixin Group Co Ltd is a China-based diversified investment holding group that integrates pharmaceuticals, property leasing and management, textiles, and financial investment. The Company consists of five business segments. The main business and assets of the Investment segment are foreign investment. The Textile segment is mainly engaged in textile fabrics and clothing. The Medical segment is mainly engaged in the production and sales of pharmaceuticals, mainly chemical drugs. The Trading segment is mainly engaged in commodity goods trading. The Industrial Park segment is mainly engaged in real estate leasing and property management. The Company conducts business in the domestic market.

  • Revenue in CNY (TTM)788.05m
  • Net income in CNY156.25m
  • Incorporated1993
  • Employees715.00
  • Location
    Shanghai Haixin Group Co LtdNo.688 Changxing RoadDongjing Town, Songjiang DistrictSHANGHAI 200001ChinaCHN
  • Phone+86 2 163917000
  • Fax+86 2 163917678
  • Websitehttps://www.haixin.com
More ▼

Institutional shareholders

7.22%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Jan 202619.57m4.18%
Chongqing International Trust Co., Ltd.as of 30 Sep 202512.63m2.69%
Vanguard Fiduciary Trust Co.as of 31 Jan 20261.38m0.30%
SSgA Funds Management, Inc.as of 05 Feb 2026150.71k0.03%
Vanguard Asset Management Ltd.as of 31 Jan 202688.74k0.02%
More ▼
Data from 31 Dec 2025 - 09 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.